Stanford Geneticist Michael Snyder Backs Biotech-Derived Skincare

Yuvan Research spent three years engineering the formula, which relies on a 3% concentration of GHK-Cu to stimulate collagen production and tissue remodeling. To ensure the peptide remains effective, the company designed a specialized air-tight delivery system that prevents oxidative degradation—a persistent hurdle for GHK-Cu stability in consumer products.

In an Institutional Review Board–approved study involving 21 volunteers, high-resolution ultrasound scans demonstrated a 28% average increase in collagen density after 90 days of use. Snyder, who directs Stanford’s Center for Genomics and Personalized Medicine, has integrated the gel into his own daily regimen for over two years. While he describes his experience as a personal testimonial, his professional focus on the biological markers of aging lends the endorsement weight rarely seen in the beauty sector. The product aims to move the skincare industry away from temporary aesthetic fixes toward regenerative biotechnology.